Concepedia

M. Khalid Ijaz

MK

43

Publications

3.5K

Citations

27

H-Index

1984

Active since

Affiliations

Reckitt Benckiser (United States)(Current)

University of Ottawa

Medgar Evers College

City University of New York

University of Saskatchewan

M. Khalid Ijaz is an author at Reckitt Benckiser (United States) specializing in medicine, virology, and microbiology.

ORCID

Top concepts

Publications per year

1984–2024

43

Publications

43

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Survival Characteristics of Airborne Human Coronavirus 229E

M. Khalid Ijaz, Al Brunner, Syed A. Sattar et al. · Journal of General Virology · 1985 · 269 citations

Rows per page

1–5 of 43